April 18th 2024
A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference assesses the link between antibiotic use and C difficile infection in Tennessee.
Understanding How Disruption of the Gut Microbiome Leads to CDI
The panel reflects on how disruption of the gut microbiome leads to the proliferation of Clostridioides difficile.
Watch
C Difficile Infection: What Causes Disruption of the Gut Microbiome?
Shared insight on how disruption of the gut microbiome may occur based on antibiotic exposure, environmental factors, and diet.
Watch
C Difficile Infection: The Importance of the Gut Microbiome
Opening their discussion on Clostridioides difficile, experts provide an overview on the gut microbiome and colonization resistance.
Watch
Investigational Therapies, Modalities May Change Recurrent C Difficile Treatment Trajectory
November 11th 2021During the C Diff Foundation's Annual conference, providers and stakeholders offered insights on the latest investigational therapies and modalities as they advance through clinical trials.
Watch
Moving Forward: Investigational C Diff Vaccine, Therapeutics Headline Conference
November 4th 2021Highlights from the morning session of the C Diff Foundation Conference included data about Pfizer's investigational vaccine, insights about Seres Therapeutics microbiome therapeutic, and a look at CDI incidence rates around COVID-19.
Read More
The Role of Antimicrobial Stewardship in Deterring C Difficile
November 4th 2021The development of these programs are being looked at for private practices in the community settings to try to create better prescribing practices and avoid the potential progression to health care associated infections.
Watch